Sutro Biopharma, Inc. (STRO)

Sutro Biopharma Revenue

In the year 2025, Sutro Biopharma had annual revenue of $102.48M with 65.18% growth. Sutro Biopharma had revenue of $11.65M in the quarter ending December 31, 2025, a decrease of -21.35%.

• Revenue (ttm): $102.48M
• Revenue Growth: +65.18%
• P/S Ratio: 3.81
• Revenue / Employee: $575,753
• Employees: 178
• Market Cap: 390.49M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	102.48M	40.44M	65.18%
Dec 31, 2024	62.04M	-91.69M	-59.64%
Dec 31, 2023	153.73M	85.96M	126.84%
Dec 31, 2022	67.77M	5.89M	9.52%
Dec 31, 2021	61.88M	19.16M	44.84%
Dec 31, 2020	42.72M	-14.00K	-0.03%
Dec 31, 2019	42.74M	4.32M	11.24%
Dec 31, 2018	38.42M	-13.32M	-25.75%
Dec 31, 2017	51.74M	-7.99M	-13.38%
Dec 31, 2016	59.73M	-	-